Drew Crawford takes helm at Benecard PBF
ORLANDO, Fla. — Former Caremark Rx executive Drew Crawford has been appointed president and CEO of Benecard PBF, an administrator of prescription benefits and services to public and private plan sponsors.
Crawford is a former member of the executive management of Caremark Rx and is the son of Mac Crawford, who served as chairman, president and CEO of Caremark Rx and also is the former chairman of CVS Caremark.
At Caremark, Crawford was responsible for all underwriting, analytic and outcome operations of the company¹s PBM business, including its specialty pharmacy and disease management units. He also led valuation, purchase and integration teams for the company’s major transactions, including its 2004 acquisition of Advance PCS and its 2007 merger with CVS.
Crawford most recently served as a principal with Crawford-Ross, a healthcare private equity joint venture.
Kansas pharmacy school dean receives award
LAWRENCE, Kan. — The dean of the Kansas University School of Pharmacy has won an award in recognition for service to the elderly, according to published reports.
The Lawrence Journal World reported Monday that dean Ken Audus had won the Douglas County Senior Center’s Seaver Award.
The article noted that the school has started many programs for local residents, such as health fairs and free bone-density screenings.
NACDS responds to proposed Rx labeling recommendations
ALEXANDRIA, Va. — Following the release of U.S. Pharmacopeia’s Proposed General Chapter Prescription Container Labeling recommendations, the National Association of Chain Drug Stores issued a letter to USP urging flexibility and an open dialogue with pharmacy and prescriber communities as review of the recommendations continues.
"The chain pharmacy industry shares the goal of providing prescription container labels that are useful for patients. Our members have devoted significant resources and time to developing prescription container labels that are designed to provide patients with the useful information that they need to take their medications as prescribed," NACDS stated in its comment letter.
In the letter, NACDS addressed concerns with some of the recommendations, including technological issues, cost concerns, legal restrictions, prescriber requirements, container and label size limitations, as well as linguistic challenges.
NACDS also highlighted the role of pharmacy in delivering medication therapy management services, which can improve medication adherence. Poor medication adherence costs the United States approximately $290 billion annually — 13% of total healthcare expenditures. Providing concise, understandable prescription container labeling can further assist patients in adhering to their medication regimens to improve health and reduce costs.
"We ask USP to consider outreach and further interaction with prescribers, pharmacies and pharmacists for further discussion, and to develop a greater understanding of the issues for pharmacies," the letter stated.